TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014
TCL Archive Audit Finds NIH Conflict of Interest Reports Scattered, Inaccessible, And Incomplete. January 25, 2008